Group Metacognitive Therapy for Severe Antidepressant and CBT Resistant Depression: A Baseline-Controlled Trial

Cognitive Therapy and Research

Volumn 39, Issue 1, 2015, Pages 14-22

  Papageorgiou, Costas ^a   Wells, Adrian ^b  

^a Priory Group   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Antidepressant; Cognitive behaviour therapy; Group therapy; Metacognitive therapy; Treatment resistant depression

Indexed keywords

EID: 84939893257     PISSN: 01475916     EISSN: 15732819     Source Type: Journal    
DOI: 10.1007/s10608-014-9632-x     Document Type: Article

References (53)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. American Psychological Association (1993). Task force on promotion and dissemination of psychological procedures. A report to the Division 12 Board of the American Psychological Association.
3. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology,56, 893–897.
4. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry,4, 561–571.
5. Ciesla, J. A., & Roberts, J. E. (2002). Self-directed thought and response to treatment for depression: A preliminary investigation. Journal of Cognitive Psychotherapy: An International Quarterly,16, 435–453.
6. Cornwall, P. L., & Scott, J. (1997). Partial remission in depressive disorders. Acta Psychiatrica Scandinavica,95, 265–271.
7. Dammen, T., Papageorgiou, C., & Wells, A. (in press). An open trial of group metacognitive therapy for depression in Norway. Nordic Journal of Psychiatry.
8. DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., et al. (2005). Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry,62, 409–416.
9. Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., et al. (2006). Randomized trial of behavioral activation, cognitive therapy and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology,74, 658–670.
10. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured clinical interview for DSM-IV axis I disorders—Patient edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute.
11. Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse and recurrence. Archives of General Psychiatry,48, 851–855.
12. Goring, H. J., & Papageorgiou, C. (2008). Rumination and worry: Factor analysis of self-report measures in depressed participants. Cognitive Therapy and Research,32, 554–566.
13. Gortner, E. T., Gollan, J. K., Dobson, K. S., & Jacobsen, N. S. (1998). Cognitive-behavioral treatment for depression: Relapse prevention. Journal of Consulting and Clinical Psychology,66, 377–384.
14. Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., et al. (2005). Prevention of relapse following cognitive therapy vs. medications in moderate to severe depression. Archives of General Psychiatry,62, 417–422.
15. Jones, N. P., Siegle, G. J., & Thase, M. E. (2008). Effects of rumination and initial severity on remission to cognitive therapy for depression. Cognitive Therapy and Research,32, 591–604.
16. Just, N., & Alloy, L. B. (1997). The response styles theory of depression: Tests and an extension of the theory. Journal of Abnormal Psychology,106, 221–229.
17. Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., et al. (2000). A comparison of nefazodone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine,342, 1462–1470.
18. Kuehner, C., & Weber, I. (1999). Responses to depression in unipolar depressed patients: An investigation of Nolen-Hoeksema’s response styles theory. Psychological Medicine,29, 1323–1333.
19. Lyubomirsky, S., & Tkach, C. (2004). The consequences of dysphoric rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 21–41). Chichester: Wiley.
20. Michalak, J., Hölz, A., & Teismann, T. (2011). Rumination as a predictor of relapse in mindfulness-based cognitive therapy for depression. Psychology and Psychotherapy,84, 230–236.
21. Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001). Secular trends in antidepressant prescribing in the UK, 1975–1998. Journal of Public Health Medicine,23, 262–267.
22. National Institute for Health and Clinical Excellence. (2004). Depression: Management of depression in primary and secondary care. National Clinical Practice Guideline Number, 23.
23. Nolen-Hoeksema, S. (1991). Responses to depression and their effects on the duration of depressive episodes. Journal of Abnormal Psychology,100, 569–582.
24. Nolen-Hoeksema, S., & Morrow, J. (1991). A prospective study of depression and posttraumatic stress symptoms after a natural disaster: The 1989 Loma Prieta earthquake. Journal of Personality and Social Psychology,61, 115–121.
25. Normann, N., van Emmerik, A. A., & Morina, N. (2014). The efficacy of metacognitive therapy for anxiety and depression: A meta-analytic review. Depression and Anxiety,31, 402–411.
26. Papageorgiou, C. (2006). Worry and rumination: Styles of persistent negative thinking in anxiety and depression. In G. C. L. Davey & A. Wells (Eds.), Worry and its psychological disorders: Theory, assessment and treatment (pp. 21–40). Chichester: Wiley.
27. Papageorgiou, C. (2009). Cognitive behaviour therapy, depressive rumination and metacognition. In G. Simos (Ed.), Cognitive behaviour therapy: A guide for the practising clinician (pp. 18–33). East Sussex: Routledge.
28. Papageorgiou, C., & Wells, A. (2000). Treatment of recurrent major depression with attention training. Cognitive and Behavioral Practice,7, 407–413.
29. Papageorgiou, C., & Wells, A. (2001). Positive beliefs about depressive rumination: Development and preliminary validation of a self-report scale. Behavior Therapy,32, 13–26.
30. Papageorgiou, C., & Wells, A. (2003). An empirical test of a clinical metacognitive model of rumination and depression. Cognitive Therapy and Research,27, 261–273.
31. Papageorgiou, C., & Wells, A. (2004). Nature, functions, and beliefs about depressive rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 3–20). Chichester: Wiley.
32. Papageorgiou, C., & Wells, A. (2009). A prospective test of the clinical metacognitive model of rumination and depression. International Journal of Cognitive Therapy,2, 123–131.
33. Papageorgiou, C., Wells, A., & Meina, L. J. (in preparation). Development and preliminary validation of the Negative Beliefs about Rumination Scale.
34. Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995). Residual symptoms after partial remission: An important outcome in depression. Psychological Medicine,25, 1171–1180.
35. Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., et al. (1999). Prevention of relapse in residual depression by cognitive therapy: A controlled trial. Archives of General Psychiatry,56, 829–835.
36. Prudic, J., Haskett, R. F., Mulsant, B., Malone, K. M., Pettinati, H. M., Stephens, S., et al. (1996). Resistance to antidepressant medications and short-term clinical response to ECT. American Journal of Psychiatry,153, 985–992.
37. Riso, L. P., du Toit, P. L., Blandino, J. A., Penna, S., Dacey, S., Duin, J. S., et al. (2003). Cognitive aspects of chronic depression. Journal of Abnormal Psychology,112, 72–80.
38. Roberts, J. E., Gilboa, E., & Gotlib, I. H. (1998). Ruminative response style and vulnerability to episodes of dysphoria: Gender, neuroticism, and episode duration. Cognitive Therapy and Research,22, 401–423.
39. Roelofs, J., Papageorgiou, C., Gerber, R. D., Huibers, M., Peeters, F., & Arntz, A. (2007). On the links between self-discrepancies, rumination, metacognitions, and symptoms of depression in undergraduates. Behaviour Research and Therapy,45, 1295–1305.
40. Roth, A., & Fonagy, P. (1996). What works for whom? A critical review of psychotherapy research. New York: Guilford Press.
41. Sackeim, H. (2001). The definition and meaning of treatment-resistant depression. Journal of Clinical Psychiatry,62, 10–17.
42. Schmaling, K. B., Dimidjian, S., Katon, W., & Sullivan, M. (2002). Response styles among patients with minor depression and dysthymia in primary care. Journal of Abnormal Psychology,111, 350–356.
43. Scott, J. (2000). Treatment of chronic depression. New England Journal of Medicine,342, 1518–1520.
44. Siegle, G. J., Ghinassi, F., & Thase, M. E. (2007). Neurobehavioral therapies in the 21st century: Summary of an emerging field and an extended example of cognitive control training for depression. Cognitive Therapy and Research,31, 235–262.
45. Spasojevic, J., & Alloy, L. B. (2001). Rumination as a common mechanism relating depressive risk factors to depression. Emotion,1, 25–37.
46. Stimpson, N., Agrawal, N., & Lewis, G. (2002). Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: Systematic review. British Journal of Psychiatry,181, 284–294.
47. Thase, M. E. (2001). The need for clinically relevant research on treatment-resistant depression. Journal of Clinical Psychiatry,62, 221–224.
48. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry,163, 28–40.
49. Wells, A. (1990). Panic disorder in association with relaxation induced anxiety: An attention training approach to treatment. Behavior Therapy,21, 273–280.
50. Wells, A. (2009). Metacognitive therapy for anxiety and depression. New York: Guilford Press.
51. Wells, A., Fisher, P. L., Myers, S., Wheatley, J., Patel, T., & Brewin, C. R. (2012). Metacognitive therapy in treatment-resistant depression: A platform trial. Behaviour Research and Therapy,50, 367–373.
52. Wells, A., & Matthews, G. (1994). Attention and emotion: A clinical perspective. Hove: Erlbaum.
53. Wells, A., & Papageorgiou, C. (2004). Metacognitive therapy for depressive rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 259–273). Chichester: Wiley.